- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06125743
Autogestion du lymphœdème et de la fibrose de la tête et du cou [essai PROMISE]
Promouvoir l'autogestion chez les survivants du cancer de la tête et du cou atteints de lymphœdème et de fibrose [essai PROMISE]
The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
In HNC survivors with lymphedema and fibrosis (LEF), the investigators will: 1) compare the effects of in-person LEF-SMP, telehealth LEF-SMP, and usual care on LEF severity; 2) compare the effects of in-person LEF-SMP, telehealth LEF-SMP, and usual care on LEF-related symptom burden, functional impairments, and quality of life; and 3) compare the effects of in-person LEF-SMP, telehealth LEF-SMP, and usual care on LEF-related knowledge, skills, self-efficacy, and self-care adherence.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Jie Deng, PhD
- Numéro de téléphone: 2155732393
- E-mail: jiedeng@nursing.upenn.edu
Lieux d'étude
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, États-Unis, 19104
- Recrutement
- University of Pennsylvania
-
Contact:
- Jie Deng, PhD
- Numéro de téléphone: 215-573-2393
- E-mail: jiedeng@nursing.upenn.edu
-
-
Tennessee
-
Nashville, Tennessee, États-Unis, 37303
- Recrutement
- Vanderbilt University Medical Center
-
Contact:
- Barbara Murphy, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- >18 years of age
- Post HNC primary treatment
- No evidence of cancer (NED)
- Completion of initial lymphedema therapy for head and neck lymphedema
- Unable to obtain lymphedema therapy due to barriers noted above
- History of lymphedema on the face and neck, with or without fibrosis
- Ability to understand English in order to complete questionnaires
- Ability to perform self-care activities for LEF management
- Ability to provide informed consent
- Having an electronic device (a computer, tablet, iPad, or smartphone) and internet access at home
- A valid email address
Exclusion Criteria:
- Recurrent or metastatic cancer
- Any other active cancer
- Acute infection
- Acute congestive heart failure
- Acute renal failure
- Cardiac or pulmonary edema
- Sensitive carotid sinus
- Severe carotid blockage
- Uncontrolled hypertension
- Venous thrombosis
- Pregnant people
- Incarcerated patients
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Autre: Soins habituels
|
Participants will conduct self-care activities prescribed by their treating lymphedema therapists. |
|
Expérimental: LEF-SMP en personne
|
Participants will receive the in-person LEF-SMP intervention. |
|
Expérimental: Télésanté LEF-SMP
|
Participants will receive the telehealth LEF-SMP intervention. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in severity of lymphedema and fibrosis
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
This outcome measure will be assessed via Head and Neck - External Lymphedema and Fibrosis Assessment Criteria (HN-LEF Assessment Criteria). The total severity score of lymphedema and fibrosis (LEF) is calculated by summing the severity score (normal = 0, mild =1, moderate =2, and severe =3) of each anatomical site affected by head and neck LEF. Higher scores mean a worse outcome. |
Baseline, 3-, 6-, and 9-months post-intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in severity of symptom burden
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
This outcome measure will be assessed via Head and Neck - Lymphedema and Fibrosis Symptom Inventory (HN-LEF Symptom Inventory). The severity score of symptom burden is dependent on the number of self-reported symptoms [overall score range: 0 (no) - 5 (severe)], and higher scores mean a worse outcome. |
Baseline, 3-, 6-, and 9-months post-intervention
|
|
Changes in degrees of jaw range of motion
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
This outcome measure will be assessed via Jaw Range of Motion Scale. Higher degrees of jaw range of motion mean a better outcome (criteria for trismus: mouth opening < 35mm). |
Baseline, 3-, 6-, and 9-months post-intervention
|
|
Changes in degrees of cervical range of motion
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
This outcome measure will be assessed via Cervical Range of Motion Instrument. Higher degrees of cervical range of motion mean a better outcome. |
Baseline, 3-, 6-, and 9-months post-intervention
|
|
Changes in quality-of-life score
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
This outcome measure will be assessed via European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). This questionnaire includes a global health-related quality of life scale, 5 functional subscales, 3 symptom scales, and 6 single items. Scores for all scales and single items are linearly converted to range from 0-100, and higher scores signify a higher quality of life. |
Baseline, 3-, 6-, and 9-months post-intervention
|
|
Changes in LEF-related knowledge score
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
LEF-related knowledge will be assessed via HN-LEF Knowledge Test scale. The scale asks participants to answer 35 true/false questions. The total score (score range: 0-35) represents participants' knowledge level related to head and neck LEF, and higher scores mean a better outcome. |
Baseline, 3-, 6-, and 9-months post-intervention
|
|
Changes in LEF-related skills
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
LEF-related skills will be assessed via HN-LEF Skill Checklist. Study lymphedema therapists use this checklist to evaluate participants' LEF self-care skills. |
Baseline, 3-, 6-, and 9-months post-intervention
|
|
LEF-related self-efficacy score
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
LEF-related self-efficacy will be assessed via Perceived Medical Condition Self-Management Scale [8-item, each item score 1 (strongly disagree) - 5 (strongly agree)]. Higher scores indicate greater self-efficacy. |
Baseline, 3-, 6-, and 9-months post-intervention
|
|
LEF-related self-care adherence status
Délai: Baseline, 3-, 6-, and 9-months post-intervention
|
LEF-related self-care adherence will be assessed via LEF Self-Care Checklist. Higher scores indicate greater better adherence to LEF self-care activities (i.e., full adherence: ≥ 5 days; partial adherence: 3-4 days; non-adherence: <3 days). |
Baseline, 3-, 6-, and 9-months post-intervention
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- UPCC# 12323
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .